Your browser doesn't support javascript.
loading
Assessing Drug Release from Manipulated Abuse Deterrent Formulations.
Feng, Xin; Zidan, Ahmed; Kamal, Nahid S; Xu, Xiaoming; Sun, Dajun; Walenga, Ross; Boyce, Heather; Cruz, Celia N; Ashraf, Muhammad.
Afiliación
  • Feng X; Center for Drug Evaluation and Research, Office of Pharmaceutical Quality, Office of Testing and Research, Division of Product Quality Research, U.S. Food and Drug Administration, Silver Spring, Maryland, 20993, USA.
  • Zidan A; Center for Drug Evaluation and Research, Office of Pharmaceutical Quality, Office of Testing and Research, Division of Product Quality Research, U.S. Food and Drug Administration, Silver Spring, Maryland, 20993, USA.
  • Kamal NS; Center for Drug Evaluation and Research, Office of Pharmaceutical Quality, Office of Testing and Research, Division of Product Quality Research, U.S. Food and Drug Administration, Silver Spring, Maryland, 20993, USA.
  • Xu X; Center for Drug Evaluation and Research, Office of Pharmaceutical Quality, Office of Testing and Research, Division of Product Quality Research, U.S. Food and Drug Administration, Silver Spring, Maryland, 20993, USA.
  • Sun D; Center for Drug Evaluation and Research, Office of Generic Drugs, Office of Research and Standards, Division of Quantitative Methods and Modeling, U.S. Food and Drug Administration, Silver Spring, Maryland, 20993, USA.
  • Walenga R; Center for Drug Evaluation and Research, Office of Generic Drugs, Office of Research and Standards, Division of Quantitative Methods and Modeling, U.S. Food and Drug Administration, Silver Spring, Maryland, 20993, USA.
  • Boyce H; Center for Drug Evaluation and Research, Office of Generic Drugs, Office of Research and Standards, Division of Quantitative Methods and Modeling, U.S. Food and Drug Administration, Silver Spring, Maryland, 20993, USA.
  • Cruz CN; Center for Drug Evaluation and Research, Office of Pharmaceutical Quality, Office of Testing and Research, Division of Product Quality Research, U.S. Food and Drug Administration, Silver Spring, Maryland, 20993, USA.
  • Ashraf M; Center for Drug Evaluation and Research, Office of Pharmaceutical Quality, Office of Testing and Research, Division of Product Quality Research, U.S. Food and Drug Administration, Silver Spring, Maryland, 20993, USA. Muhammad.Ashraf@fda.hhs.gov.
AAPS PharmSciTech ; 21(2): 40, 2020 Jan 02.
Article en En | MEDLINE | ID: mdl-31897805
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Composición de Medicamentos / Mal Uso de Medicamentos de Venta con Receta / Liberación de Fármacos / Formulaciones Disuasorias del Abuso Tipo de estudio: Prognostic_studies Idioma: En Revista: AAPS PharmSciTech Asunto de la revista: FARMACOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Composición de Medicamentos / Mal Uso de Medicamentos de Venta con Receta / Liberación de Fármacos / Formulaciones Disuasorias del Abuso Tipo de estudio: Prognostic_studies Idioma: En Revista: AAPS PharmSciTech Asunto de la revista: FARMACOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos